Transgenic animals exhibiting major disorders related to Alzheimer's disease
US7700823B2 · kind B2 · utility
2Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2004 |
| Grant date | Apr 20, 2010 |
| Priority date | — |
| Expiry date | Oct 1, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2267/0312
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to nonhuman transgenic animals exhibiting major disorders related to Alzheimer's disease. The animals can be used for demonstrating compounds intended for the treatment of Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.